I'm a Celebrity... Get Me Out of Here! viewers took no prisoners when it came to commenting on the Coming Out show's editing ...

The Cambridge biotech, the first gene editing company to go public eight years ago, is laying off 180 workers as it focuses ...

We update our picks throughout awards season, so keep checking IndieWire for all our 2025 Oscar predictions. The 2025 ACE ...

OpenAI has continued its marathon of announcements with full availability of its canvas tool. A day after OpenAI dropped its ...

Every issue is packed with photo tips, kit reviews and inspiration ...

In industry parlance, the deal joins a “delivery” company with a “cargo” company — fusing the two key pieces needed to build ...

Editas Medicine said Thursday afternoon it will lay off 65% of its staff — around 180 employees — as it shelves its lead gene-editing program for sickle cell disease and shifts focus.

Emma Reeve, the chair of Editas’ board, is also resigning, to be replaced by Jessica Hopfield, Ph.D., the company explained ...

Gene editing will be at the heart of future dairy cattle breeding programmes, according to Ai Services' chief executive.

In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Metagenomi, Inc. (MGX – Research Report), with a price ...